Literature DB >> 8121302

Serum lipid levels in growth hormone-deficient men.

H de Boer1, G J Blok, H J Voerman, M Phillips, J A Schouten.   

Abstract

To evaluate the impact of growth hormone deficiency (GHD) on lipid metabolism, serum lipid and apolipoprotein concentrations were measured in 64 GHD adult males (mean age, 27.1 +/- 4.7 years). Results were compared with those obtained from an age- and sex-matched control group. Total cholesterol, low-density lipoprotein (LDL) cholesterol, and apolipoprotein (apo) B levels were significantly higher in GHD patients (P < .001). In 14 patients (23%), total cholesterol concentration exceeded the 95th percentile for healthy adults. Total and LDL cholesterol were inversely related to plasma insulin-like growth factor-I (IGF-I). Apo B also tended to be negatively correlated with IGF-I; however, statistical significance was not reached (P = .054). High-density lipoprotein (HDL) cholesterol and plasma triglyceride concentrations were within normal limits, whereas apo A-1 and A-2 levels were only slightly different from normal. We conclude that GHD in adulthood is associated with mild hypercholesterolemia due to an increased LDL cholesterol level. An inverse relationship was established between LDL cholesterol concentration and GH secretory status.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8121302     DOI: 10.1016/0026-0495(94)90245-3

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  24 in total

1.  Intestinal permeability in adult patients with growth hormone deficiency.

Authors:  J García-Arnés; C Sierra; F Tinahones; A Monzón; M J López; N Mazuecos; F Soriguer; E Valverde
Journal:  J Endocrinol Invest       Date:  2001-02       Impact factor: 4.256

2.  Metabolic effects of discontinuing growth hormone treatment.

Authors:  F J Cowan; W D Evans; J W Gregory
Journal:  Arch Dis Child       Date:  1999-06       Impact factor: 3.791

Review 3.  Long-term growth hormone replacement therapy in hypopituitary adults.

Authors:  Johan Verhelst; Roger Abs
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 4.  Effects of GH replacement on metabolism and physical performance in GH deficient adults.

Authors:  S K Abdul Shakoor; S M Shalet
Journal:  J Endocrinol Invest       Date:  2003-09       Impact factor: 4.256

Review 5.  Unusual effects of GH deficiency in adults: a review about the effects of GH on skin, sleep, and coagulation.

Authors:  F Tanriverdi; Z Karaca; K Unluhizarci; F Kelestimur
Journal:  Endocrine       Date:  2014-05-11       Impact factor: 3.633

6.  Sex differences in the prevalence of metabolic syndrome and its components in hypopituitary patients: comparison with an age- and sex-matched nationwide control group.

Authors:  Ah Reum Khang; Eu Jeong Ku; Ye An Kim; Eun Roh; Jae Hyun Bae; Tae Jung Oh; Sang Wan Kim; Chan Soo Shin; Seong Yeon Kim; Jung Hee Kim
Journal:  Pituitary       Date:  2016-12       Impact factor: 4.107

7.  Changes in insulin levels following 6-month treatment with recombinant human growth hormone in growth hormone-deficient adults.

Authors:  D Valle; M N D Di Minno; V Palmieri; S Pezzullo; F Cirillo; C Di Somma; G Di Minno; G Lombardi
Journal:  J Endocrinol Invest       Date:  2009-07-17       Impact factor: 4.256

8.  Anthracycline causes impaired vascular endothelial function and aortic stiffness in long term survivors of childhood cancer.

Authors:  Zoltan Jenei; Edit Bárdi; Mária Tünde Magyar; Agnes Horváth; György Paragh; Csongor Kiss
Journal:  Pathol Oncol Res       Date:  2012-12-16       Impact factor: 3.201

9.  Metabolic syndrome and cardiovascular risk among long-term survivors of acute lymphoblastic leukaemia - From the St. Jude Lifetime Cohort.

Authors:  Kerri A Nottage; Kirsten K Ness; Chenghong Li; Deokumar Srivastava; Leslie L Robison; Melissa M Hudson
Journal:  Br J Haematol       Date:  2014-01-27       Impact factor: 6.998

10.  Effect of growth hormone treatment on diastolic function in patients who have developed growth hormone deficiency after definitive treatment of acromegaly.

Authors:  Pouneh K Fazeli; Jonathan G Teoh; Eleanor L Lam; Anu V Gerweck; Tamara L Wexler; Eliza P Teo; Brian M Russell; Ronen Durst; David McCarty; Rory B Weiner; Michael H Picard; Anne Klibanski; Karen K Miller
Journal:  Growth Horm IGF Res       Date:  2015-12-03       Impact factor: 2.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.